Khema R. Sharma

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

Emanuela Gussoni, Grace K. Pavlath, Andrea M. Lanctot et al. · Nature · 1992 · 427 citations

Myoblast Transplantation, Normal Dystrophin Transcripts, Pathology +4

Stroke in young adults.

Heather Bevan, Khema R. Sharma, Walter G. Bradley · Stroke · 1990 · 258 citations

Young Adults, Cerebrovascular Disease, Neurovascular Disease +20

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3